Figure 2From: p66 Shc and tyrosine-phosphorylated Shc in primary breast tumors identify patients likely to relapse despite tamoxifen therapyRelapse-free survival (RFS) according to Shc in patients with breast cancer. (a) Kaplan-Meier graphical analysis of RFS in patients from the population-based cohort partitioned by the median value for Shc (P = 0.013). (b) Kaplan-Meier graphical analysis of RFS in patients from the case-control cohort partitioned by the median value for Shc (P = 0.035).Back to article page